How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinion

Nephrol Dial Transplant. 2020 Jun 1;35(6):899-904. doi: 10.1093/ndt/gfaa130.
No abstract available

Publication types

  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections
  • Edetic Acid
  • Humans
  • Immunosuppression Therapy
  • Kidney Transplantation*
  • Pandemics
  • Pneumonia, Viral
  • SARS-CoV-2
  • Transplant Recipients

Substances

  • Edetic Acid